Home • Industry Projects • Ceftobiprole - Injectable Anti-MRSA Cephalosporin Antibiotic • Image 5

Ceftobiprole medocaril (BAL5788) is the product of a joint development programme between Basilea Pharmaceutica AG and Cilag AG International (a Johnson & Johnson company).

«Back	|	Next»

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |